4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-21-000128
Chairman, CEO & President sold 5,535 shares at an average $379.88 ($2,102,626)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SAYER KEVIN R Chairman, CEO & President | 2021-05-03 | Sale | −2,543 | $376.33 | $957,014 | 108,714 | D |
| SAYER KEVIN R Chairman, CEO & President | 2021-05-03 | Sale | −487 | $376.98 | $183,590 | 108,227 | D |
| SAYER KEVIN R Chairman, CEO & President | 2021-05-03 | Sale | −248 | $377.97 | $93,737 | 107,979 | D |
| SAYER KEVIN R Chairman, CEO & President | 2021-05-03 | Sale | −126 | $378.99 | $47,753 | 107,853 | D |
| SAYER KEVIN R Chairman, CEO & President | 2021-05-03 | Sale | −500 | $382.48 | $191,240 | 107,353 | D |
| SAYER KEVIN R Chairman, CEO & President | 2021-05-03 | Sale | −300 | $384.91 | $115,473 | 107,053 | D |
| SAYER KEVIN R Chairman, CEO & President | 2021-05-03 | Sale | −1,331 | $386.04 | $513,819 | 105,722 | D |
| Open-market sales · 5,535 sh · avg $379.88 · $2,102,626 | |||||||
Loading xslF345X03/edgardoc.xml…